Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Lupus Erythematosus (LE) is an autoimmune disorder that includes a broad spectrum of clinical
forms. One of these forms, Discoid Lupus Erythematosus (DLE) is a chronic disfiguring disease
confined to the skin.
The aim of this pivotal trial is to investigate the efficacy and safety of ASF-1096 cream
0.5% in the treatment of patients with DLE or SLE presenting newly developed discoid lesions.